Agne Giedraitiene
Overview
Explore the profile of Agne Giedraitiene including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giedraitiene A, Ruzauskas M, Siugzdiniene R, Tuckute S, Grigonis K, Milcius D
Nanomaterials (Basel)
. 2024 Aug;
14(15).
PMID: 39120368
Cotton textiles improved with metal oxide nanoparticles acquire additional features that may enhance their action against antimicrobial-resistant pathogens due to the unique properties and characteristics of the nanoparticles. The main...
2.
cereskevicius D, Zabiela V, Aldujeli A, Lesauskaite V, Zubieliene K, Raskevicius V, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791422
The effectiveness of lipid-lowering therapies may be insufficient in high-risk cardiovascular patients and depends on the genetic variability of drug-metabolizing enzymes. Customizing statin therapy, including treatment with atorvastatin, may improve...
3.
Giedraitiene A, Tatarunas V, Kaminskaite K, Meskauskaite U, Boieva S, Ajima Y, et al.
Diagnostics (Basel)
. 2024 Mar;
14(5).
PMID: 38473018
Background: Ischemic heart disease (IHD) is the most prevalent type of cardiovascular disease. The main cause of IHD is atherosclerosis, which is a multifactorial inflammatory disease of blood vessels. Studies...
4.
Tatarunas V, ciapiene I, Giedraitiene A
Pharmaceutics
. 2024 Feb;
16(2).
PMID: 38399346
Interindividual variability in drug response is a major problem in the prescription of pharmacological treatments. The therapeutic effect of drugs can be influenced by human genes. Pharmacogenomic guidelines for individualization...
5.
Giedraitiene A, Ruzauskas M, Siugzdiniene R, Tuckute S, Grigonis K, Milcius D
Nanomaterials (Basel)
. 2023 Dec;
13(24).
PMID: 38133003
Antibacterial textiles can help prevent infections from antimicrobial-resistant pathogens without using antibiotics. This work aimed to enhance the cotton fabric's antimicrobial properties by depositing FeO nanoparticles on both sides of...
6.
Giedraitiene A, Ruzauskas M, Siugzdiniene R, Tuckute S, Milcius D
Materials (Basel)
. 2022 Nov;
15(22).
PMID: 36431382
Medical face masks help to reduce the transmission of pathogens, however, the number of infections caused by antimicrobial-resistant pathogens continues to increase. The aim of this study was to investigate...
7.
Meskauskaite U, Andruskeviciute S, ciapiene I, Giedraitiene A, Lesauskaite V, Tatarunas V
Drug Des Devel Ther
. 2022 Aug;
16:2559-2568.
PMID: 35959420
Background: Antiplatelet drugs, such as ticagrelor, which target platelet P2Y receptors, are used for prevention of ischemic heart disease. Ticagrelor is also known to have pleiotropic effects of unknown mechanisms....
8.
Giedraitiene A, Pereckaite L, Bredelyte-Gruodiene E, Virgailis M, ciapiene I, Tatarunas V
Future Microbiol
. 2022 May;
17:789-802.
PMID: 35549350
ESBL-producing and bacterial biofilms-forming are associated with antimicrobial treatment failure. This study aimed to investigate the phenotypic resistance mechanisms of CTX-M against old antibiotics - cell wall synthesis inhibitors temocillin,...
9.
Tatarunas V, Aldujeli A, Kurnickaite Z, Maciulevicius L, Burkanas M, Venius J, et al.
Per Med
. 2022 Feb;
19(3):207-217.
PMID: 35172619
The goals of this study were to develop a new technique that could pave the way for a quicker determination of rs3093135 and rs4244285 variants directly from a patient's blood...
10.
Liutkevicius V, Tamauskaite T, Vilkeviciute A, Liutkeviciene R, Smalinskaite R, Giedraitiene A, et al.
Stomatologija
. 2020 Jul;
22(1):3-8.
PMID: 32706340
Objective: Fibroblast growth factor receptor 2 (FGFR2) is a member of the FGFR family of tyrosine kinase receptors, which via cell growth, invasiveness, motility and angiogenesis contributes to the process...